Clinical Trials Directory

Trials / Completed

CompletedNCT00277732

Pharmaceutical Care for Diabetes Type 2 Patients: a Randomised Controlled Trial

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
288 (actual)
Sponsor
University Ghent · Academic / Other
Sex
All
Age
45 Years – 75 Years
Healthy volunteers
Not accepted

Summary

The objective of this study is to evaluate the therapeutic effectiveness and cost-effectivity of pharmaceutical care for diabetes type 2 patients. Patients will be randomly allocated to the control group ( = no input from pharmacist) or intervention group ( = with pharmaceutical care at baseline and follow-up visits over 6 months).

Conditions

Interventions

TypeNameDescription
PROCEDUREPharmaceutical care at baseline and follow-up visits over 6 months

Timeline

Start date
2006-01-01
Completion
2006-11-01
First posted
2006-01-16
Last updated
2007-12-28

Locations

1 site across 1 country: Belgium

Source: ClinicalTrials.gov record NCT00277732. Inclusion in this directory is not an endorsement.

Pharmaceutical Care for Diabetes Type 2 Patients: a Randomised Controlled Trial (NCT00277732) · Clinical Trials Directory